Giselle Sholler, Division Chief of Pediatric Hematology and Oncology at Penn State Health Children’s Hospital, shared a post on LinkedIn: 

“Our newest publication highlights the preclinical work that was critical in obtaining DFMO approval is available!

The approval required a single arm trial with ‘substantial confirmatory evidence’ shown here.
So proud of our team, especially Divya for her ‘first author’ paper – congratulations!”

Additional information.
Source: Giselle Sholler/LinkedIn